Abstract
AimsPeripheral T cell lymphomas represent approximately 10%–15% of non-Hodgkin lymphomas and are characterised by an aggressive clinical courses and poor outcomes. Ligands provided by constituents of the tumour microenvironment engage...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have